isoproterenol has been researched along with pentoxifylline in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 5 (29.41) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Deo, S; Nair, KG; Nandi, JS | 1 |
| Herman, G; Mauduit, P; Rossignol, B | 1 |
| Hatake, K; Hishida, S; Marukawa, S; Wakabayashi, I | 1 |
| Beleta, J; Bou, J; Cardelús, I; Cortijo, J; Gristwood, RW; Llenas, J; Morcillo, E | 1 |
| Ibrahim, IN; Kadowitz, PJ; Kaye, AD; Nossaman, BD | 1 |
| Babin-Chevaye, C; Franzini, E; Hakim, J; Pasquier, C; Sellak, H | 1 |
| Babin-Chevaye, C; Franzini, E; Hakim, J; Marquetty, C; Pasquier, C; Sellak, H | 1 |
| Chilcoat, CD; Jones, SL; Rowlingson, KA | 1 |
| Anamourlis, C; Badenhorst, D; Gibbs, M; Maseko, M; Norton, GR; Osadchii, O; Woodiwiss, AJ | 1 |
| Norton, G; Osadchii, O; Woodiwiss, A | 1 |
| Ahmadi, SH; Dehpour, AR; Ebrahimi, F; Ghasemi, M; Hajrasouliha, AR; Rofoui, BR; Sadeghipour, H; Tavakoli, S | 1 |
| Azhar, A; El-Bassossy, HM | 1 |
| Abdelghafour, AM; Ali, SI; Elseweidy, MM; Hammad, SK; Shaheen, MA | 1 |
1 review(s) available for isoproterenol and pentoxifylline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for isoproterenol and pentoxifylline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition cAMP-phosphodiesterase in the rat heart by pentoxifylline--a new xanthine derivative.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Body Weight; Dose-Response Relationship, Drug; Heart; Isoproterenol; Male; Organ Size; Pentoxifylline; Proteins; Rats; Theobromine; Xanthenes | 1980 |
Protein secretion induced by isoproterenol or pentoxifylline in lacrimal gland: Ca2+ effects.
Topics: Animals; Bucladesine; Calcium; Carbachol; Cyclic AMP; Isoproterenol; Kinetics; Lacrimal Apparatus; Male; Papaverine; Pentoxifylline; Proteins; Rats; Rats, Inbred Strains; Theobromine | 1984 |
Vasorelaxant effects of oxpentifylline and theophylline on rat isolated aorta.
Topics: Animals; Aorta, Thoracic; Arginine; Dose-Response Relationship, Drug; Drug Interactions; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitroarginine; Nitroprusside; Pentoxifylline; Rats; Rats, Wistar; Theophylline; Vasodilator Agents | 1994 |
Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Aged; Animals; Asthma; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Female; Guinea Pigs; Humans; In Vitro Techniques; Isoenzymes; Isoproterenol; Male; Middle Aged; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rolipram; Theophylline; Xanthines | 1993 |
Analysis of responses to pentoxifylline in the pulmonary vascular bed of the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Arginine; Bronchodilator Agents; Cats; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Interactions; Isoproterenol; Meclofenamic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentoxifylline; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Thromboxane A2; Vasodilator Agents | 1996 |
Effects of pentoxifylline on the adherence of polymorphonuclear neutrophils to oxidant-stimulated human endothelial cells: involvement of cyclic AMP.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Cell Adhesion; Cells, Cultured; Cyclic AMP; Endothelium, Vascular; Humans; Isoproterenol; Neutrophils; Oxidants; Pentoxifylline; Phosphodiesterase Inhibitors; Reactive Oxygen Species | 1995 |
Inhibition of human neutrophil binding to hydrogen peroxide-treated endothelial cells by cAMP and hydroxyl radical scavengers.
Topics: 1-Methyl-3-isobutylxanthine; Analysis of Variance; Bucladesine; Cell Adhesion; Cells, Cultured; Cyclic AMP; Deferoxamine; Endothelium, Vascular; Free Radical Scavengers; Glutathione; Humans; Hydrogen Peroxide; Hydroxyl Radical; Hypoxanthine; Isoproterenol; Neutrophils; Pentoxifylline; Tetradecanoylphorbol Acetate; Thrombin; Transferrin; Umbilical Veins; Xanthine Oxidase | 1996 |
The effects of cAMP modulation upon the adhesion and respiratory burst activity of immune complex-stimulated equine neutrophils.
Topics: Adrenergic beta-Agonists; Animals; Antigen-Antibody Complex; Cell Adhesion; Clenbuterol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Horses; Isoproterenol; Neutrophils; Pentoxifylline; Phosphodiesterase Inhibitors; Respiratory Burst; Rolipram | 2002 |
A phosphodiesterase inhibitor promotes the premature development of adverse cardiac remodelling mediated by beta-adrenergic activation in hypertension.
Topics: Adrenergic beta-Agonists; Animals; Collagen; Dilatation, Pathologic; Drug Therapy, Combination; Echocardiography; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Isoproterenol; Myocardium; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Transducers; Ventricular Remodeling | 2004 |
Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Animals; Blood Pressure; Cardiomegaly; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Organ Size; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rolipram | 2005 |
Pentoxifylline improves reoxygenation-induced contractile recovery through a nitric oxide-dependent mechanism in rat papillary muscles.
Topics: Adrenergic beta-Agonists; Animals; Enzyme Inhibitors; Hypoxia; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Papillary Muscles; Pentoxifylline; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 2006 |
Pentoxifylline alleviates cardiac ischemia and dysfunction following experimental angina in insulin resistance.
Topics: Adiponectin; Administration, Oral; Angina Pectoris; Animals; Diet; Disease Models, Animal; Electrocardiography; Inflammation; Insulin Resistance; Isoproterenol; Lipids; Male; Myocardial Contraction; Myocardial Ischemia; Pentoxifylline; Protective Agents; Rats; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2014 |
Vanillin and pentoxifylline ameliorate isoproterenol-induced myocardial injury in rats
Topics: Animals; Inflammation; Isoproterenol; Myocardial Infarction; Myocardium; Oxidative Stress; Pentoxifylline; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Vascular Endothelial Growth Factor A | 2023 |